Biomarkers and mechanistic approaches in environmental epidemiology.

Environmental epidemiological research involves the identification of relationships between previous exposures to putative causative agents and subsequent biological effects with study populations. Such relationships are often hard to fully characterize because of difficulties in accurately quantifying exposure, dose, and effect. Biomarkers are indicators, residing in biological systems or samples, of exposure, dose, effect, or susceptibility. Biomarkers of exposure indicate the presence of previous exposure to an environmental agent; a biomarker of dose bears a quantitative relationship to previous exposure or dose; these include exogenous substances, interactive products, or interactions that change the status of the target molecule. Biomarkers of effect indicate the presence and magnitude of a biological response to exposure to an environmental agent; these include endogenous components, or measures of the functional capacity or state of the system. Biomarkers of susceptibility indicate an elevated sensitivity to the effects of an environmental agent; these include the presence or absence of an endogenous component, or abnormal functional responses to an administered challenge. The development of molecular biomarkers for environmental agents is based upon specific knowledge of metabolism, interactive product formation, and general mechanisms of action. The validation of any biomarker-effect link requires parallel experimental animal and human epidemiological studies.

[1]  S. Hecht,et al.  Biomarkers for human uptake and metabolic activation of tobacco-specific nitrosamines. , 1994, Cancer research.

[2]  W. F. Athas,et al.  Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. , 1991, Cancer research.

[3]  J. Links,et al.  Regional deposition of inhaled fog droplets: preliminary observations. , 1989, Environmental health perspectives.

[4]  H. Bartsch,et al.  Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer. , 1992, Toxicology letters.

[5]  N Dubin,et al.  Blood levels of organochlorine residues and risk of breast cancer. , 1993, Journal of the National Cancer Institute.

[6]  F. Perera,et al.  Cigarette smoking related polycyclic aromatic hydrocarbon-DNA adducts in peripheral mononuclear cells. , 1992, Carcinogenesis.

[7]  D. Grant,et al.  A simple test for acetylator phenotype using caffeine. , 1984, British journal of clinical pharmacology.

[8]  S. Rappaport,et al.  A field method for measuring solvent vapors in exhaled air--application to styrene exposure. , 1991, Scandinavian journal of work, environment & health.

[9]  M. Simic,et al.  Dietary modulation of DNA damage in human. , 1991, Mutation research.

[10]  J. Groopman,et al.  Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. , 1992, Cancer research.

[11]  N. Polissar,et al.  The etiology of breast cancer characteristic alterations in hydroxyl radical‐induced dna base lesions during oncogenesis with potential for evaluating incidence risk , 1993, Cancer.

[12]  D. Grant,et al.  Molecular mechanism of slow acetylation of drugs and carcinogens in humans. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Wands,et al.  Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa , 1991, Nature.

[14]  P. Vineis,et al.  Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. , 1993, European journal of cancer.

[15]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[16]  F. Perera,et al.  Molecular epidemiology of lung cancer and the modulation of markers of chronic carcinogen exposure by chemopreventive agents , 1993, Journal of cellular biochemistry. Supplement.

[17]  P B Farmer,et al.  Relevance of urinary DNA adducts as markers of carcinogen exposure. , 1992, Chemical research in toxicology.

[18]  N. Cohen,et al.  Estimation of skeletal burden of "bone-seeking" radionuclides in man from in vivo scintillation measurements of the head. , 1977, Health physics.

[19]  C. Wild,et al.  Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment. , 1990, Cancer research.

[20]  Howard Hu,et al.  X-ray fluorescence: issues surrounding the application of a new tool for measuring burden of lead. , 1989, Environmental research.

[21]  C. Harris,et al.  p53: at the crossroads of molecular carcinogenesis and risk assessment. , 1993, Science.

[22]  R. Lotan,et al.  Biomarkers as intermediate end points in chemoprevention trials. , 1990, Journal of the National Cancer Institute.

[23]  F. Perera,et al.  Molecular and genetic damage in humans from environmental pollution in Poland , 1992, Nature.

[24]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[25]  B. Henderson,et al.  Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma , 1992, The Lancet.

[26]  P. Vineis,et al.  Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. , 1991, Pharmacogenetics.

[27]  E. Reed,et al.  Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients. , 1992, Cancer research.